Shipments totaled 2,738 units in the first quarter 2020, up 128 units or +4.9% vs. prior year. This achievement was driven by a 5.7% increase in sales of 8 cylinder models (V8) and a 2.4% increase of 12 cylinder models (V12). Volumes rose despite deliveries being suspended earlier than expected due to the Covid-19 pandemic. Robust deliveries for the 488 Pista and the 488 Pista Spider, along with the ramp up of the F8 Tributo, more than offset the 488 GTB and the 488 Spider which concluded their lifecycle in 2019. Deliveries of the Ferrari Monza SP1 and SP2 were mostly in line with our expectations.
EMEA⁽⁶⁾ grew by +25.4%, Rest of APAC⁽⁶⁾ increased by +23.2%, Americas⁽⁶⁾ was up +4.2%, while Mainland China, Hong Kong and Taiwan posted lower shipments as a consequence of the deliberate anticipation of deliveries in 2019.

Net revenues for the first quarter 2020 were Euro 932 million, almost in line with prior year, while down -2.7% at constant currency⁽¹⁾. The increase of revenues in Cars and spare parts⁽⁷⁾ to Euro 788 million (+7.3% or +5.0% at constant currency⁽¹⁾) was driven by sales of the 488 Pista and 488 Pista Spider, along with the ramp up of the F8 Tributo. The Ferrari Monza SP1 and SP2 as well as personalization programs also supported the revenue growth in the Cars and spare parts. This was partially offset by lower sales of the 488 GTB and the 488 Spider, which concluded their lifecycle in 2019, along with lower shipments of the FXX-K EVO. Engines⁽⁸⁾ revenues (Euro 33 million, -44.2% also at constant currency⁽¹⁾) continued to decline, reflecting lower shipments to Maserati. Sponsorship, commercial and brand⁽⁹⁾ revenues (Euro 89 million, -30.0% or -30.5% at constant currency⁽¹⁾) were impacted by the Covid-19, including the temporary suspension of the Formula 1 season resulting in a reduced number of Formula 1 races and corresponding lower revenue accrual in the first quarter as well as reduced in-store traffic and museum visitors. Currency – including translation and transaction impacts as well as foreign currency hedges – had a positive impact of Euro 18 million (mainly USD).

Adjusted EBITDA⁽¹⁾and Adjusted EBIT⁽¹⁾

Q1 2020 Adjusted EBIT⁽¹⁾ was Euro 220 million, -5.2% or -11.9% at constant currency⁽¹⁾ mostly due to the Covid-19 impact on Formula 1, partially offset by higher volumes (Euro 12 million) and a positive Mix / price variance (Euro 37 million). The latter was primarily attributable to the deliveries of the Ferrari Monza SP1 and SP2 and to the impact of the personalization programs, while it was partially offset by lower shipments of the FXX-K EVO. Industrial costs / research and development costs increased (Euro 15 million), mainly due to higher depreciation and amortization of fixed assets. This also included the full cost of employees’ paid days of absence during the Covid-19 production suspension and investments in Formula 1 racing activities. SG&A increased (Euro 11 million) mainly due to the annualization of the increase in staffing throughout 2019 and marketing initiatives in the early part of the first quarter of 2020. Other (down Euro 52 million) decreased due to the Covid-19 impact on the Formula 1 racing calendar, lower engine sales to Maserati as well as lower traffic for brand related activities. Other in Q1 2019 included an Euro 10 million positive impact from the favorable reassessment of a legal dispute.

Financial charges in the quarter increased to Euro 13 million, up Euro 6 million versus prior year, reflecting both a decrease in the fair value of investments held by the Group and an increase in foreign exchange losses and hedging costs.

The tax rate in the quarter was 20%, mainly attributable to the effects of Patent Box, deductions for eligible research and development costs and the hyper and super-depreciation of fixed assets in accordance with tax regulations in Italy.

As a result of the items described above, Adjusted diluted earnings⁽¹⁾ per share for the quarter reached Euro 90 cents, down -5.3% vs. the corresponding prior year period.

Industrial free cash flow⁽¹⁾ for the quarter ended March 31, 2020, was Euro 73 million, driven by Adjusted EBITDA⁽¹⁾, partially offset by capital expenditures⁽¹¹⁾ of Euro 174 million, including the purchase of tracts of land contiguous to our facilities in Maranello, and negative change in working capital due to the seasonal pattern of trade payables. The prior year was boosted by the collection of the Ferrari Monza SP1 and SP2 advances.

Net Industrial Debt⁽¹⁾ as of March 31, 2020, was Euro 401 million, compared to Euro 337 million as of December 31, 2019. During the first quarter 2020, a total of Euro 130 million of share repurchases were accomplished. Lease liabilities per IFRS 16 as of March 31, 2020, were Euro 72 million.

As of March 31, 2020, total available liquidity was Euro 1,230 million. In April 2020, additional committed credit lines of Euro 350 million were secured with tenors ranging from 18 to 24 months, therefore doubling total committed credit lines available and undrawn as of today to Euro 700 million.

Revised Guidance 2020

This revised guidance for 2020 relies upon several key assumptions and actions taken, which are summarized here below:

• The guidance range reflects different and partial recovery rates of production volumes lost during the Covid-19-related suspension in 2020, and alternative scenarios in respect of the evolution of the order book in 2020;
• A significant reduction in Formula 1 revenues reflecting the lower number of races estimated to take place during the 2020 season, with many races expected to be held without fans present;
• Brand activities project a substantial reduction in turnover to reflect a slow recovery to pre-pandemic levels;
• SG&A and R&D spending reflects containment initiatives taken and prioritization based on medium term impact analysis;
• Capital expenditures projected for 2020 reduced to approximately Euro 750 million;
• Impact of the Covid-19 pandemic to affect primarily second quarter results;
• Due to significant uncertainties relating to a potential second wave of infections of Covid-19, such scenario was not considered.

Considering the aforementioned assumptions, the Group’s guidance for the year is revised as follows:

First quarter 2020 highlights

Suspension of production in Maranello and Modena due to the Covid-19
On March 14, 2020, Ferrari announced the decision to suspend production in Maranello and Modena in light of the spread of the Covid-19 pandemic and Ferrari subsequently extended the suspension of its manufacturing activity until May 3, 2020, in accordance with the Government announcement. Ferrari will gradually restart its Maranello and Modena plants on May 4, 2020. They will return to full production on Friday May 8, 2020.

2020 Formula 1 World Championship
The start of the 2020 Formula 1 World Championship has been postponed and there is uncertainty regarding the number and format of Grand Prix races that will take place in 2020, impacting our sponsorship and commercial revenues as we have accrued revenues in the first quarter based on the estimated number of races that will take place for the 2020 season, which is expected to be significantly less than the 2019 season.

Subsequent events

Termination of the third tranche of the disclosed multi-year share repurchase program
On April 1, 2020, Ferrari announced that it would temporarily suspend its multi-year share repurchase program in its Third Tranche (with Euro 154 million executed out of a total of Euro 200 million) and, consequently, to early terminate its non-discretionary share repurchase agreement in place.

“Back on Track”, Ferrari's program to protect the health of employees upon the restart of production
Back on Track is Ferrari's program to safeguard the health of employees upon the restart of production. It entails voluntary blood screenings that provide an overview of the health status of the Ferrari Community and the possible use of an app, currently being tested, that will keep people informed through contact based tracing. With these measures the Company is taking care of its most precious resource, its people, facilitating the safest and most worry-free possible return to working life. Ferrari will share results with the Emilia Romagna Region, making the most advanced practices for the protection of workers' health available to the broader community.

Dividend distribution
On April 16, 2020, the Ferrari’s Annual General Meeting of Shareholders approved a dividend in cash of Euro 1.13 per outstanding common share, an increase of nearly 10% compared to the prior year, totaling approximately Euro 210 million, to be paid on May 5, 2020.

Ferrari initiatives on the Covid-19
Ferrari has joined the collective fight against the Covid-19 through several solidarity projects.
The Company has launched a fundraising among some of its clients, matching all of their donations. Funds will be destined to the medical staff and the health system of Ferrari’s surrounding communities.
Other initiatives in the local community include the purchasing of equipment for local hospitals, emergency medical service vehicles, IT equipment for schools and essential goods for struggling families coping with the emergency situation. The overall funds donated for these specific initiatives, of almost Euro 2 million, were generated thanks to the Chairman, the CEO and Board of Directors pledging their full compensation from April to the end of the year, with the Senior Management Team donating 25% of their salaries for the same period.
These contributions add to respirator valves and fittings for protective masks produced by the Company at its Maranello plant and donated to Italian hospitals. Ferrari, with other companies, contributed to sourcing and purchasing a total of 210 ventilators, alongside other medical equipment from various overseas suppliers, providing for their immediate air transport to Italy.

Capex and R&D

Non-GAAP financial measures
Operations are monitored through the use of various non-GAAP financial measures that may not be comparable to other similarly titled measures of other companies.

Accordingly, investors and analysts should exercise appropriate caution in comparing these supplemental financial measures to similarly titled financial measures reported by other companies.

We believe that these supplemental financial measures provide comparable measures of financial performance which then facilitate management’s ability to identify operational trends, as well as make decisions regarding future spending, resource allocations and other operational decisions.

Certain totals in the tables included in this document may not add due to rounding.

Total Net Revenues, EBITDA, Adj. EBITDA, EBIT and Adj. EBIT at constant currency eliminate the effects of changes in foreign currency (transaction and translation) and of foreign currency hedges.

EBITDA is defined as net profit before income tax expense, net financial expenses and depreciation and amortization.
Adjusted EBITDA is defined as EBITDA as adjusted for certain income and costs which are significant in nature, expected to occur infrequently, and that management considers not reflective of ongoing operational activities.

Adjusted Earnings Before Interest and Taxes (“Adjusted EBIT”) represents EBIT as adjusted for certain income and costs which are significant in nature, expected to occur infrequently, and that management considers not reflective of ongoing operational activities.

Adjusted net profit represents net profit as adjusted for certain income and costs (net of tax effect) which are significant in nature, expected to occur infrequently, and that management considers not reflective of ongoing operational activities.

Adjusted EPS represents EPS as adjusted for certain income and costs (net of tax effect) which are significant in nature, expected to occur infrequently, and that management considers not reflective of ongoing operational activities.

Basic and diluted EPS⁽¹³⁾